Activation of B-raf in Non-Malignant Nevi Predicts a Novel Tumor Suppressor Gene in Melanoma (MAP Kinase Phosphatase)
- 1 November 2003
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (5)
- https://doi.org/10.1046/j.1523-1747.2003.12583.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mutations of the BRAF Gene in Benign and Malignant Melanocytic LesionsJournal of Investigative Dermatology, 2003
- Adhesion-dependent Activation of the ERK1/2 Cascade Is By-passed in Melanoma CellsJournal of Biological Chemistry, 2003
- Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) SignalingJournal of Biological Chemistry, 2003
- High frequency of BRAF mutations in neviNature Genetics, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- p16Ink4a in Melanocyte Senescence and DifferentiationJNCI Journal of the National Cancer Institute, 2002
- Mutations and Copy Number Increase of HRAS in Spitz Nevi with Distinctive Histopathological FeaturesPublished by Elsevier ,2000
- Molecular genetics of familial cutaneous melanoma.Journal of Clinical Oncology, 1998